摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Benzenehexanol, 4-bromo- | 877926-53-9

中文名称
——
中文别名
——
英文名称
Benzenehexanol, 4-bromo-
英文别名
6-(4-bromophenyl)hexan-1-ol
Benzenehexanol, 4-bromo-化学式
CAS
877926-53-9
化学式
C12H17BrO
mdl
——
分子量
257.17
InChiKey
YSYLFPUWBJGPEH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    14
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    20.2
  • 氢给体数:
    1
  • 氢受体数:
    1

文献信息

  • DIARYLETHER DERIVATIVES AS ANTITUMOR AGENTS
    申请人:Matsuyama Hironori
    公开号:US20100004438A1
    公开(公告)日:2010-01-07
    An object of the present invention is to provide a medicinal drug much improved in anti tumor activity and excellent in safety. According to the present invention, there is provided a medicinal drug containing a compound represented by the following general formula (1) or a salt thereof as an active ingredient: [Formula 1] wherein X 1 represents a nitrogen atom or a group —CH═, R 1 represents a group -Z-R 6 , in which Z represents a group —CO—, a group —CH(OH)— or the like, R 6 represents a 5- to 15-membered monocyclic, dicyclic or tricyclic saturated or unsaturated heterocyclic group having 1 to 4 nitrogen atoms, oxygen atoms or sulfur atoms, R 2 represents a hydrogen atom or a halogen atom, Y represents a group —O—, a group —CO—, a group —CH(OH)— or a lower alkylene group, and A represents [Formula 2] wherein R 3 represents a hydrogen atom, a lower alkoxy group or the like, p represents 1 or 2, R 4 represents an imidazolyl lower alkyl group or the like.
    本发明的一个目的是提供一种在抗肿瘤活性方面大大改进且安全性优异的药物。根据本发明,提供了一种包含以下一般式(1)所表示的化合物或其盐作为活性成分的药物:[式1]其中X1代表氮原子或基团—CH═,R1代表一个基团-Z-R6,其中Z代表基团—CO—,基团—CH(OH)—或类似的基团,R6代表一个含有1至4个氮原子、氧原子或硫原子的5至15个成员的单环、双环或三环饱和或不饱和杂环基团,R2代表氢原子或卤原子,Y代表基团—O—,基团—CO—,基团—CH(OH)—或低碳烷基基团,A代表[式2]其中R3代表氢原子、低碳氧基基团或类似基团,p代表1或2,R4代表咪唑基低碳基团或类似基团。
  • [EN] EP2 RECEPTOR AGONISTS<br/>[FR] AGONISTES DU RECEPTEUR EP2
    申请人:PHARMAGENE LAB LTD
    公开号:WO2005061449A1
    公开(公告)日:2005-07-07
    A compound selected from Formula (iv) or Formula (iii); (iv) (1R,2S)-2[4-1(S)-hydroxyhexyl)phenyl]-5-oxo-cyclopentaneheptanoic acid [RSS] or (iii) (1R,2S)-2[4-1(R)-hydroxyhexyl)phenyl]-5-oxo-cyclopentaneheptanoic acid [RSR] or a salt, solvate, chemically protected form or prodrug thereof, and its use in treating conditions alleviated by agonism of an EP2 receptor.
    从公式(iv)或公式(iii)中选择的化合物;(iv)(1R,2S)-2-[4-1(S)-羟基己基)苯基]-5-氧代环戊酰基庚酸[ RSS]或(iii)(1R,2S)-2-[4-1(R)-羟基己基)苯基]-5-氧代环戊酰基庚酸[ RSR]或其盐、溶剂合物、化学保护形式或前药,以及其在治疗通过EP2受体激动而缓解的病症中的应用。
  • [EN] TETRAZOLINONE COMPOUNDS AND ITS USE<br/>[FR] COMPOSÉS DE TÉTRAZOLINONE ET LEUR UTILISATION
    申请人:SUMITOMO CHEMICAL CO
    公开号:WO2013162077A1
    公开(公告)日:2013-10-31
    The present invention provides a compound having an excellent efficacy for controlling pests. A tetrazolinone compound of a formula (1): [wherein, R1 represents an C6-C16 aryl group, an C1-C12 alkyl group, a C3-C12 cycloalkyl group or an adamantyl group, etc., which each optionally be substituted; R2 represents a hydrogen atom, an C1-C12 alkyl group, or a halogen atom, etc.; R4 and R5 represent independently of each other a hydrogen atom or an C1-C3 alkyl group, etc.; R6, R7, R8 and R9 represent independently of each other a hydrogen atom, a halogen atom, an C1-C12 alkyl group, a C1-C12 haloalkyl group, an C2-C12 alkenyl group, a C3-C12 cycloalkyl group, an C1-C12 alkoxy group or a C1-C12 haloalkoxy group, etc.; X and Y represent independently of each other a sulfur atom or an oxygen atom; Q represents an oxygen atom or a sulfur atom; and R10 represents an C1-C6 alkyl group, etc.] shows an excellent controlling efficacy on pests.
    本发明提供了一种具有优异杀虫效果的化合物。式(1)中的四氮杂酮化合物:[其中,R1代表一个C6-C16芳基,一个C1-C12烷基,一个C3-C12环烷基或一个金刚烷基等,每个都可以选择性地被取代;R2代表一个氢原子,一个C1-C12烷基或一个卤素原子等;R4和R5分别独立地代表一个氢原子或一个C1-C3烷基等;R6、R7、R8和R9分别独立地代表一个氢原子,一个卤素原子,一个C1-C12烷基,一个C1-C12卤代烷基,一个C2-C12烯基,一个C3-C12环烷基,一个C1-C12烷氧基或一个C1-C12卤代烷氧基等;X和Y分别独立地代表一个硫原子或一个氧原子;Q代表一个氧原子或一个硫原子;R10代表一个C1-C6烷基等]对害虫有极佳的控制效果。
  • Aromatic Compounds
    申请人:Fukushima Tae
    公开号:US20070270422A1
    公开(公告)日:2007-11-22
    The present invention provides a novel compound, which has an excellent effect of suppressing the generation of collagen and less side effects, with being excellent in terms of safety. The compound of the present invention is represented by the following general formula (1): [wherein X 1 represents a nitrogen atom or a group —CH═; R 1 represents a group -Z-R 6 , wherein Z represents a group —CO—, a group —CH(OH)—, or the like, and R 6 represents a 5- to 15-membered monocyclic, dicyclic, or tricyclic, saturated or unsaturated heterocyclic group having 1 to 4 nitrogen atoms, oxygen atoms, or sulfur atoms; R 2 represents a hydrogen atom, a halogen atom or a lower alkylene group; Y represents a group —O—, a group —CO—, a group —CH(OH)—, a lower alkylene group, or the like; and A represents a group or the like, wherein R 3 represents a hydrogen atom, a lower alkoxy group, or the like, p represents 1 or 2, and R 4 represents an imidazolyl lower alkyl group or the like.
    本发明提供了一种新型化合物,具有抑制胶原生成的优异效果,并且具有较少的副作用,在安全性方面表现出色。本发明的化合物由以下通式(1)表示:[其中X1代表氮原子或基团—CH═;R1代表基团-Z-R6,其中Z代表基团—CO—、基团—CH(OH)—或类似基团,而R6代表具有1到4个氮原子、氧原子或硫原子的5-到15元的单环、双环或三环、饱和或不饱和杂环基团;R2代表氢原子、卤素原子或低碳链基团;Y代表基团—O—、基团—CO—、基团—CH(OH)—、低碳链基团或类似基团;A代表基团或类似基团,其中R3代表氢原子、低碳醚基团或类似基团,p代表1或2,而R4代表咪唑基低碳基团或类似基团。
  • AROMATIC COMPOUND
    申请人:FUKUSHIMA Tae
    公开号:US20120238750A1
    公开(公告)日:2012-09-20
    The compound of the present invention is represented by the following general formula (1): [wherein X 1 represents a nitrogen atom or a group —CH═; R 1 represents a group —Z—R 6 , wherein Z represents a group —CO—, a group —CH(OH)—, or the like, and R 6 represents a 5- to 15-membered monocyclic, dicyclic, or tricyclic, saturated or unsaturated heterocyclic group having 1 to 4 nitrogen atoms, oxygen atoms, or sulfur atoms; R 2 represents a hydrogen atom, a halogen atom or a lower alkylene group; Y represents a group —O—, a group —CO—, a group —CH(OH)—, a lower alkylene group, or the like; and A represents a group or the like, wherein R 3 represents a hydrogen atom, a lower alkoxy group, or the like, p represents 1 or 2, and R 4 represents an imidazolyl lower alkyl group or the like.
    本发明的化合物由以下通式(1)表示:[其中X1表示氮原子或基团—CH═; R1表示基团—Z—R6,其中Z表示基团—CO—、基团—CH(OH)—或类似物,而R6表示具有1至4个氮原子、氧原子或硫原子的5至15环的单环、双环或三环、饱和或不饱和的杂环基团; R2表示氢原子、卤素原子或较低的烷基链; Y表示基团—O—、基团—CO—、基团—CH(OH)—、较低的烷基链或类似物; A表示基团或类似物,其中R3表示氢原子、较低的烷氧基或类似物,p表示1或2,而R4表示咪唑基较低的烷基链或类似物。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐